Navigation Links
Zebrafish provide useful screening tool for genes, drugs that protect against hearing loss
Date:2/29/2008

A small striped fish is helping scientists understand what makes people susceptible to a common form of hearing loss, although, in this case, its not the fishs ears that are of interest. In a study published in the Feb. 29 issue of the journal PLoS Genetics, researchers at the University of Washington have developed a research method that relies on a zebrafishs lateral linethe faint line running down each side of a fish that enables it to sense its surroundingsto quickly screen for genes and chemical compounds that protect against hearing loss from some medications. The study was funded in part by the National Institute on Deafness and Other Communication Disorders (NIDCD), one of the National Institutes of Health.

The fishs lateral line contains sensory cells that are functionally similar to those found in the inner ear, except these are on the surface of the fishs body, making them more easily accessible, said James F. Battey, Jr., M.D., Ph.D., director of the NIDCD. This means that scientists can very efficiently analyze the sensory structures under different conditions to find out what is likely to cause damage to these structures and, conversely, what can protect them from damage.

When people are exposed to some antibiotics and chemotherapy agents, the sensory structures in the inner ear, called hair cells, can be irreversibly damaged, resulting in hearing loss and balance problems. Such medications are called ototoxic. People vary widely in their susceptibility to these agents as well as to damage caused by other chemical agents, loud sounds and aging.

To find out why this is so, senior scientists Edwin Rubel, Ph.D., David Raible, Ph.D. and their research team developed a screening strategy that uses hair cells in the lateral line of zebrafish larvae to signal how hair cells in a persons inner ear might respond under similar conditions. Hair cells are named for small bristly extensions, or stereocilia, jutting from their tops. M
'/>"/>

Contact: Jennifer Wenger
jwenger@mail.nih.gov
301-496-7243
NIH/National Institute on Deafness and Other Communication Disorders
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Phylonix granted broad European patent for transplanting human cells into zebrafish
2. Transparent zebrafish help researchers track breast cancer
3. NIH awards Phylonix phase II SBIR to develop zebrafish models for eye diseases
4. Microbiotic technology developed for microinjection of zebrafish embryos
5. Johnson & Johnson Diabetes Institute, LLC Launches New Center to Provide State-of-the-Art Education, Training to Health Professionals
6. Crdentia Selected by Leading Staffing Vendor to Provide Health Care Staffing Services to One of the Largest Hospital Chains in the U.S.
7. Hooper Holmes to Provide Business Update
8. XCPT(TM) Patient Engagement and Communication Software and DentalXP.com, a Leading Provider of Online Dental Education and Content, Sign a Co-Marketing Agreement
9. AMN Healthcare Reports Fourth Quarter and Year End 2007 Results; Provides Full Year 2008 Guidance
10. HASP Online Provides Free Job Safety Analysis Tool Available Online
11. Microsoft to Showcase Innovative Solutions for Healthcare Providers and Consumers at HIMSS 2008 Annual Conference & Exhibition

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... A jury of 8 people in the Wester...woman $2,300,000 in pain and suffering for a medic...mes Tallman and Alicia Nocera of Thomas E. Crenney... the plaintiff, Vita Monestersky and against the U...ency total abdominal hysterectomy at age 18. , ...
(Date:11/8/2009)...ation,s largest network of Hispanic health advocat...eform in 2009 ,, WASHINGTON, Nov. 7 /PRNewswir...entatives showed they have heard the voice of Amer...re for America Act. Now the Senate must deliver, w...care reform," said Dr. Jane L. Delgado, President ...
(Date:11/8/2009)...alls for Swift Passage of H.R. 3961 to Secure the ...wswire-USNewswire/ -- Statement Attributable to: J...Association. ,, (Logo: http://www.newscom.com...hails the passage of the House health reform bill,...ients and physicians and calls for swift passage o...
(Date:11/8/2009)...ealth Care Vote Shows Who Sides With Working Famil..., Nov. 8 On the heels o...esentatives for a good, balanced health care refor...ing of how our state,s U.S. representatives voted ... Act. ,, The legislation, which passed Saturda...
(Date:11/7/2009)...SHINGTON, Nov. 7 Karen ...urance Plans (AHIP), released the following statem...alth plans strongly support comprehensive health c...sion by proposing a complete overhaul of how healt...posed guaranteed coverage, elimination of pre-exis...
Breaking Medicine News(10 mins):Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:AHIP Statement on House Passage of H.R. 3962 2
...ns Growthink to Raise $2 Million Dollars in ...S, June 18 Growthink, the leading Investment,Bank...ging and Middle,Market Enterprises, announced toda... by the Food, Beverage,Pharmaceutical and Health S...
...uray,Incorporated (Nasdaq: ARAY ), a global leade...t its president and chief executive officer, Euan ...Jefferies Healthcare,Conference on Thursday, June ...any,s Web site at, http://www.accuray.com . The we...
...itment to Securing Confidential Customer ...SKING RIDGE, N.J. and NEWPORT BEACH, Calif., June ...re technology solutions,serving nearly half of the...ybertrust Enterprise Certification., By meeting t...
... University, Gentag,Inc., and Science Applications...combined forces to develop a non-invasive method f...rs agreed to combine their,respective intellectual...ting products could eliminate the need for finger,...
...e Integrase(TM) assays used to study ... FRANCISCO, Calif., June 18 Monogram,Biosciences,...ompany has,signed an agreement with Gilead Science...tients for study,enrollment and help select drugs ...
...new Lumax 540 technologies together with BIOTRONIK...d patient management that,provides daily protectio... BIOTRONIK GmbH & Co KG, the pioneer in wireless ...es, which,includes implantable cardioverter defibr...
Other Medicine News:Health News:Pop! Technology Goes Growthink 2Health News:Accuray Incorporated's CEO to Speak at Jefferies Second Annual Healthcare Conference 2Health News:TriZetto Maintains Prestigious Verizon Business Security Certification for Sixth Consecutive Year 2Health News:TriZetto Maintains Prestigious Verizon Business Security Certification for Sixth Consecutive Year 3Health News:TriZetto Maintains Prestigious Verizon Business Security Certification for Sixth Consecutive Year 4Health News:No More Needles? Georgetown University Teams with Gentag and SAIC to Develop New Glucose Sensor Technology with Wireless Connection to Cell Phones 2Health News:No More Needles? Georgetown University Teams with Gentag and SAIC to Develop New Glucose Sensor Technology with Wireless Connection to Cell Phones 3Health News:Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies 2Health News:Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies 3Health News:Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies 4Health News:Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies 5Health News:Tomorrow's care today: Lumax 540 cardiac devices launched at Cardiostim 2Health News:Tomorrow's care today: Lumax 540 cardiac devices launched at Cardiostim 3
(Date:11/6/2009)...Newswire-FirstCall/ -- Recession in domestic and i...r Allied Healthcare Products in the first quarter ..., Sales declines pushed Allied into a loss for th... $745,000, or negative 9 cents per share, compared...0, or 3 cents per share. ,, Sales fell about 2...
(Date:11/6/2009)...Newswire/ -- Trius Therapeutics, Inc. announced to...Form S-1 with the U.S. Securities and Exchange Com...c offering of shares of its common stock. All shar...will be offered by the Company. ,, Credit Suiss...ing manager, Piper Jaffray & Co. is acting as ...
(Date:11/6/2009)...6 Repossessions and liquidations o...d quarter of 2009 declined as compared to similar ...ement,s NasTrac Quarterly Index (NQI). The figure...both repossessions and orderly liquidations, also ...ction and printing equipment, offering mixed news ...
Breaking Medicine Technology:Recession Continues to Depress Sales at Allied Healthcare Products 2Recession Continues to Depress Sales at Allied Healthcare Products 3Recession Continues to Depress Sales at Allied Healthcare Products 4Recession Continues to Depress Sales at Allied Healthcare Products 5Recession Continues to Depress Sales at Allied Healthcare Products 6NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 3NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 4LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 1LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 2LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 3LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 4SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 1SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 2SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 3SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 4SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 5PDL BioPharma Elects Barry Selick to Its Board of Directors 53479 1PDL BioPharma Elects Barry Selick to Its Board of Directors 53479 2
... New product recently approved by FDA for long-ter...n; data demonstrate,first nebulized formoterol fum...o dry powder formoterol, enhanced patient quality ... (May 20, 2007) – Data presented at the,Inte...ety (ATS),demonstrate that Perforomist™ (for...
...BRIDGE, Mass.--(BUSINESS WIRE)--May 16, 2007 - Glo... biopharmaceutical,company, announced today that t...nted Fast Track designation for its novel histone,...rapy of,previously treated peripheral T-cell lymph...hat it has reached an agreement with the,FDA under...
Other Medicine Technology:Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 2Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 3Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 4Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 7Gloucester Pharmaceuticals Receives Fast Track Designation for,Romidepsin in Peripheral T-Cell Lymphoma 2Gloucester Pharmaceuticals Receives Fast Track Designation for,Romidepsin in Peripheral T-Cell Lymphoma 3
Dodick-Kammann Nucleus Chopper
Chang Phaco Chopper
Denman Brown Nucleus Cracker
Forceps Epilation Angled End B510.10 3.5"
Medicine Products: